Grace Capital’s MyoKardia MYOK Stock Holding History
Bought
Maintained
Sold
Grace Capital's MYOK Position: Q4 2020 in Review
Grace Capital sold out of MyoKardia (MYOK) in Q4 2020, closing a stake of 23,400 shares — an estimated $3.19M sold.
Grace Capital first reported a position in MYOK in Q2 2018 and held it in 10 quarters. The position peaked at $8.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Grace Capital reported no remaining MyoKardia position as of Q4 2020 after selling out during the quarter.
- Grace Capital sold 23,400 MyoKardia shares in Q4 2020, an estimated $3.19M.
- Grace Capital first reported a position in MyoKardia in Q2 2018 and held it in 10 quarters.
- Grace Capital's MyoKardia position peaked at $8.8M in Q2 2018.
- 0 funds tracked by Wall St. Rank held MyoKardia as of Q4 2020.
Based on Grace Capital's 13F filing for Q4 2020, filed 10 Feb 2021.